Form 10 Explorer
10-Q
Quarterly Report
MiniMed Group, Inc.

MMED

NASDAQ

CIK: 2062583

File #: 001-43183

Period End: Jan 23, 2026

Fiscal Year: 2026

View on EDGAR
Balance Sheet
31 line items · 2 periods
XBRL
ItemJan 23, 2026Apr 25, 2025
ASSETS
Current assets:
Cash and cash equivalents
10,000,00011,000,000
Accounts receivable, less allowances and credit losses of $64 and $46, respectively
653,000,000570,000,000
Inventories
408,000,000311,000,000
Other current assets
37,000,00048,000,000
Total current assets
1,108,000,000939,000,000
Property, plant, and equipment, net
701,000,000706,000,000
Goodwill
2,256,000,0002,255,000,000
Other intangible assets, net
113,000,000132,000,000
Tax assets
19,000,00019,000,000
Other assets
146,000,000150,000,000
Total assets
4,343,000,0004,201,000,000
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
303,000,000205,000,000
Accrued compensation
184,000,000182,000,000
Accrued rebates
48,000,00051,000,000
Italy
15,000,000
Other accrued expenses
161,000,000271,000,000
Total current liabilities
696,000,000710,000,000
Other liabilities
184,000,000162,000,000
Total liabilities
881,000,000871,000,000
Parent company equity:
Net investment from Parent
3,449,000,0003,328,000,000
Accumulated other comprehensive income
14,000,0003,000,000
Total Parent company equity
3,462,000,0003,330,000,000
Parent company investment
3,449,000,0003,328,000,000
Accumulated other comprehensive income (loss)
14,000,0003,000,000
Cumulative Translation Adjustments
14,000,0003,000,000
Total liabilities and Parent company equity
4,343,000,0004,201,000,000
MiniMed Group, Inc. (MMED) — 10-Q Filing | Form 10 Explorer